[go: up one dir, main page]

KR900005980A - Anti-inflammatory α-[[(2-hydroxy-1,1-dimethyl-ethyl) amine] methyl] benzene methanol hydrochloride (EL-508) - Google Patents

Anti-inflammatory α-[[(2-hydroxy-1,1-dimethyl-ethyl) amine] methyl] benzene methanol hydrochloride (EL-508) Download PDF

Info

Publication number
KR900005980A
KR900005980A KR1019880013689A KR880013689A KR900005980A KR 900005980 A KR900005980 A KR 900005980A KR 1019880013689 A KR1019880013689 A KR 1019880013689A KR 880013689 A KR880013689 A KR 880013689A KR 900005980 A KR900005980 A KR 900005980A
Authority
KR
South Korea
Prior art keywords
hydroxy
dimethyl
amine
ethyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019880013689A
Other languages
Korean (ko)
Inventor
몽포로 페르낭도
깔라따위드 죠제
마뉴엘·뤼나
Original Assignee
원본미기재
에스뻬셜리데드스 라티나스 메디까망토스 위니베르살레스 에스.아.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 에스뻬셜리데드스 라티나스 메디까망토스 위니베르살레스 에스.아. filed Critical 원본미기재
Priority to KR1019880013689A priority Critical patent/KR900005980A/en
Publication of KR900005980A publication Critical patent/KR900005980A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

내용 없음No content

Description

항염증 작용의 α-[[(2-하이드록시-1, 1-디메틸-에틸)아민]메틸]벤젠 메탄올 하이드로클로라이드(EL-508)Anti-inflammatory α-[[(2-hydroxy-1, 1-dimethyl-ethyl) amine] methyl] benzene methanol hydrochloride (EL-508)

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (9)

다음 구조식을 갖는 α-[[(2-하이드록시-1,1-디메틸-에틸)아민]메틸]벤젠 메탄올 하이드로클로라이드의 치료적 효과량을 염증이 있는 대상자에게 투여하는 것으로 구성되는 염증의 치료방법.A method of treating inflammation consisting of administering a therapeutically effective amount of α-[[(2-hydroxy-1,1-dimethyl-ethyl) amine] methyl] benzene methanol hydrochloride to the inflamed subject having the structure . 제1항에 있어서, 상기 대상자에게 투여하는 방법이 경구적 주입에 의한 것인 방법.The method of claim 1, wherein the method of administering to the subject is by oral infusion. 제1항에 있어서, 상기 치료적 효과량이 약 100mg/체중 kg인 방법.The method of claim 1, wherein said therapeutically effective amount is about 100 mg / kg body weight. 제1항에 있어서, 상기 투여방법이 국소적 도포에 의한 것인 방법.The method of claim 1, wherein the method of administration is by topical application. 제4항에 있어서, 상기 치료적 효과량이 수성 또는 알콜 용액내 6% 농도인 방법.The method of claim 4, wherein said therapeutically effective amount is a 6% concentration in aqueous or alcoholic solution. 제1항에 있어서, 상기 투여방법이 질 관주법에 의한 것인 방법.The method of claim 1, wherein the administration method is by vaginal irrigation. 제6항에 상기 치료적 효과량이 5%농도의 용액인 방법.The method of claim 6, wherein the therapeutically effective amount is a solution at a concentration of 5%. 다음 구조식의 α-[[(2-하이드록시-1,1-디메틸-에틸)아민]메틸]벤젠 메탄올 하이드로클로라이드로 구성된 항염증제.An anti-inflammatory agent consisting of α-[[(2-hydroxy-1,1-dimethyl-ethyl) amine] methyl] benzene methanol hydrochloride of the formula: 제약학적으로 허용가능한 부형제 또는 시약, 및 다음 구조식인 α-[[(2-하이드록시-1,1-디메틸-에틸)아민]메틸]벤젠 메탄올 하이드로클로라이드의 치료적 효과량으로 구성된 제약학적 조성물.A pharmaceutical composition comprising a pharmaceutically acceptable excipient or reagent and a therapeutically effective amount of the following structural formula α-[[(2-hydroxy-1,1-dimethyl-ethyl) amine] methyl] benzene methanol hydrochloride. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019880013689A 1988-10-20 1988-10-20 Anti-inflammatory α-[[(2-hydroxy-1,1-dimethyl-ethyl) amine] methyl] benzene methanol hydrochloride (EL-508) Withdrawn KR900005980A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019880013689A KR900005980A (en) 1988-10-20 1988-10-20 Anti-inflammatory α-[[(2-hydroxy-1,1-dimethyl-ethyl) amine] methyl] benzene methanol hydrochloride (EL-508)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019880013689A KR900005980A (en) 1988-10-20 1988-10-20 Anti-inflammatory α-[[(2-hydroxy-1,1-dimethyl-ethyl) amine] methyl] benzene methanol hydrochloride (EL-508)

Publications (1)

Publication Number Publication Date
KR900005980A true KR900005980A (en) 1990-05-07

Family

ID=68158370

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880013689A Withdrawn KR900005980A (en) 1988-10-20 1988-10-20 Anti-inflammatory α-[[(2-hydroxy-1,1-dimethyl-ethyl) amine] methyl] benzene methanol hydrochloride (EL-508)

Country Status (1)

Country Link
KR (1) KR900005980A (en)

Similar Documents

Publication Publication Date Title
CA1146070A (en) Topical triethylenetetramine-containing pharmaceutical compositions and methods of use
KR900700089A (en) Pharmaceutical Compositions for Systemic Skin Permeable Administration
KR920702216A (en) Use of Acetyl D-Carnitine in Glaucoma Treatment
ES2117642T3 (en) PHARMACEUTICAL PREPARATION CONTAINING N-GLYCOFUROLES AND N-ETILEN GLYCOLS.
EP0916347B1 (en) Pharmaceutical injectable solutions containing paracetamol and combinations of paracetamol with other active substances
KR880002515A (en) Fast absorbing and acting sullindac or a mixture of sodium sullindak and base
KR900701282A (en) Treatment, prevention of ischemic diseases of the heart or brain
KR910019618A (en) Pharmaceutical composition for treating erectile dysfunction
FR2712807B1 (en) Solid mucoadhesive, therapeutic or hygienic composition, for administration by application to the oral or nasal mucosa.
KR940008694A (en) Pharmaceutical composition containing L-carnitine and acyl L-carnitine for long-term treatment of non-insulin dependent diabetic patients and use thereof
KR950007848A (en) Treatment of Anxiety with (S)-(-)-α-ethyl-2-oxo-1-pyrrolidineacetamide
KR860000865A (en) Preparation of Pharmaceutical Formulations
KR830002510A (en) Composition consisting of biologically active compound and hydroxyalkyl starch
US20050203175A1 (en) Parenteral composition of paracetamol
KR920000326A (en) Use of GM₁monosialogangliosides and their internal ester derivatives in humans to prevent the development of resistance to the analgesic effects of morphine and homologues in humans
KR900005974A (en) Sexual Dysfunction in Men
KR890006227A (en) Phenol-containing antitussive liquid composition
US3629412A (en) Topical anti-inflammatory agent
KR910002442A (en) Methods and pharmaceutical compositions for treating ocular disease
KR890012942A (en) 5-substituted ornithine derivatives
KR900011461A (en) Therapeutics using trypstatin as an active ingredient
KR900005980A (en) Anti-inflammatory α-[[(2-hydroxy-1,1-dimethyl-ethyl) amine] methyl] benzene methanol hydrochloride (EL-508)
KR900701278A (en) Bile acids for the treatment of viral infections
KR880004810A (en) Peptic Ulcer Treatment
KR930003913A (en) Methods and pharmaceutical compositions for enhancing the antitussive effect of dextromethorphan

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19881020

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid